Are you confident your medicinal batches will pass regulatory scrutiny across all EU member states? Many companies outsource batch release only to discover that subtle differences in national approval procedures or registration registers undermine their Qualified Person qualification, risking delays, non-compliance, or even bans. By understanding EU core requirements and national nuances, you can choose outsourced QP services that guarantee legally sound, fully recognized Qualified Person qualification wherever you operate.

What are the core EU requirements that define qualified person qualification?

The regulatory basis of Qualified Person qualification in the EU is set by Directive 2001/83/EC (human medicinal products) and Directive 2001/82/EC (veterinary products), particularly Articles 48-51 of 2001/83. Member States must ensure that the holder of a manufacturing authorisation has permanently and continuously at their disposal at least one QP who meets the requirements of education and experience.

Specifically, the QP must hold a university degree (or equivalent recognised qualification) in pharmacy, medicine, veterinary medicine, chemistry, pharmaceutical chemistry & technology, or biology. They must also have acquired at least two years of practical experience in quality control, manufacturing, or related pharmaceutical production under GMP.

Additionally, EU GMP Annex 16 (Certification by a Qualified Person and Batch Release) requires that each batch of a medicinal product must be certified by the QP only after all checking and testing are completed and after confirming compliance with marketing authorisation and GMP. This places the QP in a unique position of personal legal responsibility.

For companies outsourcing this role, choosing professional QP release services ensures the external provider meets these EU statutory standards. This includes proper academic credentials, documented experience, and official recognition by the national competent authorities.

How do national registers approve and recognize a qualified person?

While EU Directives lay down baseline requirements for Qualified Person qualification, each Member State transposes these into national law, often adding or interpreting requirements in local registers. National registers are formal databases (or systems) maintained by competent authorities that verify a person’s eligibility to act as a QP in that jurisdiction. To be listed, a candidate typically must:

• Submit proof of education (degree in one of the recognised disciplines).
• Demonstrate required practical experience (manufacturing, QC, GMP) relevant to the types of products they will release.
• Show compliance with any national-specific requirements, such as language ability, local professional licence, residency or additional examinations/interviews.

At Billev Pharma East we assist clients to verify that their QP candidate is actually included (or can be included) in relevant national registers, ensuring recognition for the specific product types and jurisdictions in question.

Membership in the national register means the competent authority has accepted the person’s education, experience, and compliance with the local law; this grants legal status for batch certification and release in that country. Without registration, even someone meeting EU-level educational and experiential criteria may be unable to perform QP duties legally.

Which professional experiences are essential for qualified person qualification in the EU?

The educational prerequisites for Qualified Person qualification must be complemented by substantial hands-on experience. EU Directive 2001/83/EC (Art. 49) requires at least two years of practical work in a manufacturing environment authorised to produce medicinal products, involving quality control, quantitative analysis of active substances, and testing the finished products.

Key types of experience often demanded include:

• Pharmaceutical manufacturing or processing under GMP, including sterile production or aseptic operations.
• Quality control / analytical chemistry work, both qualitative and quantitative.
• Handling batch documentation, deviations, CAPA, change control, stability studies.
• Interaction with inspections or audits by national or EU authorities.

When outsourcing QP duties, companies should ask for documented experience in the same product categories (e.g. biologicals, sterile, non-sterile etc.) because nuances differ. A QP experienced in non-sterile tablets may not have the same competence in sterile injectables.

These experiences help ensure that the QP can evaluate all critical factors when certifying a batch: from manufacturing records, test reports, stability, any deviations, to confirming compliance with the marketing authorisation.

National expectations in experience for qualified person qualification

In the EU legal framework, Qualified Person qualification requires at least two years of practical experience in GMP authorised sites, covering product testing and quality assurance tasks. However, Member States often interpret “practical experience” differently: what one country considers sufficient may not satisfy another’s requirement for experience with particular product types (sterile vs non-sterile), local language documentation, or specific roles like change control or stability studies. In some national registers, a QP candidate must show directly relevant manufacturing or control activities, whereas in others related analytical or laboratory work under GMP is accepted so long as responsibilities are documented, and the environment is comparable.

Companies outsourcing or hiring external QPs must thus ensure the provider’s experience aligns not only with EU minimums but also with the national expectations of the markets where batch release will take place, so that the Qualified Person qualification is recognised and accepted in those jurisdictions.

How do country-specific rules complicate outsourcing of qp release?

Even though EU law harmonises the core criteria of Qualified Person qualification, national implementations vary. Some countries impose additional requirements beyond the directives. Examples include mandatory fluency in the local language for reading, writing, and understanding batch documentation; local licensing or professional body membership; or residency requirements.

Moreover, how educational qualifications or practical experience are assessed can differ. For instance, if a degree omission in certain subjects occurs, some Member States require supplementary courses or examinations. National authorities might interpret GMP guidance with stricter or more detailed expectations.

For companies outsourcing the batch release or QP functions, these variations mean that a QP recognised in one Member State may not be fully accepted in another. This can delay product launch, increase costs (for additional qualifications or registration), or lead to non-compliance.

Therefore, when selecting an outsourced QP provider, you should verify which national rules apply for the target market(s), confirm that the QP is authorised there, and that their qualifications/experience meet local criteria.

What evaluation criteria should companies apply when selecting an external QP?

To select an external QP service partner, these evaluation criteria are critical to ensure proper Qualified Person qualification and minimize regulatory risk:

• Legal recognition: the QP must be formally recognised by the competent authority in the relevant Member State(s) for your product type.
• Education & academic credentials: degree in pharmacy, chemistry, biology, etc., with documented equivalence if needed.
• Relevant hands-on experience in GMP manufacturing, QC, batch certification for comparable product categories.
• A proven track record with regulatory authorities: evidence of successful audits, compliant batch releases.
• Transparent integration with your quality system, including deviation handling and change control.
• Full understanding of marketing authorisation and GMP compliance, including recent updates in guidance or regulation.

Also important: the provider’s transparency in their processes, availability (does the QP commit to timely responses), and liability/responsibility agreements. Using these criteria, you can assess whether an outsourced QP service will effectively deliver compliant batch release and support regulatory compliance across jurisdictions.

What makes an external QP’s credentials stand out

When choosing an external QP, businesses often find themselves navigating vague claims of competence, so the real test of Qualified Person qualification lies in observing how a provider demonstrates depth rather than breadth. It’s not enough for a QP to simply show a degree or generic experience; what separates a reliable external QP is evidence of consistent performance under regulatory scrutiny, such as successful batch certifications or clean inspections, especially in the same product categories your company handles. Transparency in documentation—batch records, audit outcomes, how deviations and change control have been managed—often reveals more about a QP’s capability than any résumé alone.

Equally important is how the external QP aligns with your quality system. If their approach to GMP, supplier qualification, stability testing, or documentation doesn’t integrate well with your internal controls, even a highly qualified person might struggle to deliver a compliant batch release. And since national and EU requirements shift, you’ll want to see that the external QP stays current—whether through training, refresher audits, or recent exposure to evolving GMP expectations.

Ultimately, what stands out is a Qualified Person qualification that’s not just formally correct, but practically proven; credentials linked to outcomes, clarity in records, demonstrable regulatory familiarity, and adaptability to your product type and market jurisdiction.

How can businesses verify qualified person qualification across different national systems?

Verifying Qualified Person qualification across EU Member States requires systematic due diligence because interpretations and registrations vary. Steps may include:

1. Reviewing baseline EU Directives (2001/83/EC & 2001/82/EC) and EU GMP Annex 16, which define education, experience, and the role of the QP in detail.
2. Checking national competent authority registers: many countries maintain official lists of QPs. Request proof of registration, including areas covered, product types, validity period.
3. Examining product-type and manufacturing process experience: ensure the candidate has worked on similar types of products in similar regulatory environments (sterile, biologicals, etc.).
4. Verifying any additional local requirements (language, residency, additional exams) and that the QP meets them.
5. Asking for documentation: diplomas/certificates, CV with details of GMP work, audit reports, inspection history.

This approach helps avoid engaging a QP without legal authority in your target market, which could lead to non-release, regulatory non-conformities, or delays.

Why is qualified person qualification critical for compliant outsourced QP services?

The importance of Qualified Person qualification cannot be overstated when outsourcing QP services:

• A properly qualified and recognised QP holds legal responsibility for certifying that medicinal batches are manufactured and tested in accordance with GMP and marketing authorisation. EU directives and Annex 16 make clear that this responsibility cannot be delegated.
• Without proper qualifications or registration, batch certifications may be invalid or rejected by regulatory authorities, risking product recall, import bans, or legal penalties.
• The outsourced QP must have sufficient transparency and traceability — they must have access to full batch records, test results, deviation investigations, supplier audits etc., to make informed decisions.
• Given that national rules vary, making sure the QP can operate in your jurisdictions ensures that outsourcing doesn’t introduce hidden risk.

Overall, Qualified Person qualification is central to responsible oversight of batch releases, patient safety, and regulatory compliance. For companies outsourcing this capacity, rigorous evaluation and verification of the QP’s credentials is essential for trustworthiness and risk mitigation.

Read also:

• 7 key elements: what should a CAPA Plan include to address audit findings and audit observations?
• Why are GMP guidelines and GMP requirements essential for compliance?

Sources: 1 – European QP Association. (n.d.). QP regulations: legal basis for Qualified Persons in Europe, 2 – European Commission / ECA Academy. (2015). EU GMP Annex 16: Certification by a Qualified Person and Batch Release, 3 – European Medicines Agency. (2014). Guidance for the template for the qualified person’s declaration concerning GMP compliance of active substance manufacture, 4 – EQPA / GMP-Journal. (2021). QP qualification requirements in different Member States, 5 – Danish Medicines Agency. (n.d.). Requirements and expectations for the qualified person in a manufacturer/importer authorisation (MIA).